Search
Human Longevity Inc. (HLI) Launched to Promote Healthy Aging Using Advances in Genomics and Stem Cell Therapies
SAN DIEGO, March 4, 2014 — Human Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, was announced today by co-founders J. Craig Venter, Ph.D., Robert Hariri, M.D., Ph.D., and Peter H. Diamandis, M.D. The company, headquartered in San Diego, California, is being capitalized with an initial $70 million in investor funding. HLI's funding is being used to build the largest human...
World's Leading Genomic Researchers to Gather at 12th International Genome Sequencing and Analysis Conference
PRESS RELEASE World's Leading Genomic Researchers to Gather at 12th International Genome Sequencing and Analysis Conference June 5, 2000 ROCKVILLE, MD -- The Institute for Genomic Research (TIGR) announced today that it will hold its 12th Annual International Genome Sequencing and Analysis Conference (GSAC) on Tuesday, September 12 through Friday, September 15, 2000 at the Fontainebleau Hilton Resort and Towers in Miami, Florida. Recent advances in genomics are the primary focus of...
International Team of Researchers Develops New Tool to Elucidate the Epigenome
MILAN, ITALY — March 24, 2009 — An innovative technology for the rapid and reliable screening of the human epigenome (the set of functional DNA elements that regulate gene state and activity) is being developed by an international team of scientists at the IFOM-IEO Campus in Milan, in collaboration with a group from the J. Craig Venter Institute led by Samuel Levy, Ph.D., and a team from Sangamo BioSciences, Inc., led by Fyodor Urnov. The technology provides a new tool for...
About Hamilton Smith
Hamilton Smith, M.D. is a distinguished professor emeritus at the J. Craig Venter Institute and former director of the Synthetic Biology and Bioenergy Group that created the first synthetic cell in 2010 and designed and synthesized the first minimal bacterial genome in 2016. He received an A.B. degree in Mathematics from the University of California, Berkeley in 1952 and the M.D. degree from the Johns Hopkins School of Medicine in 1956. He completed a residency in Internal Medicine in 1962.
Countdown to GSAC 2000
September 05, 2000 ROCKVILLE, MD - The 2000 Annual Meeting of the International Genome Sequencing and Analysis Conference (GSAC) is nearly upon us. Beginning Tuesday, September 12 through Friday, September 15, nearly 3000 attendees from around the world will gather in Miami Beach, Florida to discuss recent advances in genomics and more. First held in 1989, GSAC has become one of the most unique and important meetings throughout the genome community attracting the world's leading...
Help Take the Bite Out of Cancer
Cancer is one of the most dreaded diseases people face. And oral cancers are some of the most vexing to treat. Oral squamous cell carcinoma or OSCC, a very common type of head and neck cancer, characterized by visible tumor lesions in the mouth, affects more than 450,000 people each year. Approximately 60% of new cases are diagnosed during its later stages when the cancer is already metastatic. These alarming statistics are motivating JCVI researchers to focus their efforts on this disease,...
Minimal Cell Workshop
4th Minimal Cell Workshop The Minimal Cell Workshop virtual series is an annual event that brings together the worldwide community of researchers working with JCVI's minimized cell, JCVI-syn3.0 (or one of its variants). JCVI-syn3.0 is based on the naturally occurring Mycoplasma mycoides, but with roughly half as many genes. This model organism has proven to be a platform for exploring the first principles of life, a chassis for engineering, computational modeling, and more. Interested...
Genomic-Based Prospective Medicine Collaboration Announced by Duke University Medical Center and The Center for the Advancement of Genomics
5/29/2003 - ROCKVILLE, Md. and DURHAM, N.C. -- The Center for the Advancement of Genomics (TCAG) and Duke University Medical Center (DUMC) today announced a formal collaboration to create the first fully integrated, comprehensive practice of genomic-based prospective medicine. Through this new collaboration, Duke and TCAG plan to generate predictive and prognostic data on specific diseases that can aid both doctors and patients in the earlier detection and better treatment of these...
Media Day Circus On Sorcerer II
June 23nd On Monday June 21st we announced the official start of the Mediterranean leg of the Sorcerer II Global Ocean Sampling Expedition. Dr. Venter took time from his busy schedule to fly into Valencia and attend the event as well as representatives from The Life Technology Foundation. The first part of the day was dedicated to media (newspapers, radio and T.V.), which included local Valencia and national outlets from Madrid. For more on press information please click here, on the...